Insider trades
Daniel Patrick O'Day, Chairman of Gilead Sciences GILD, has filed 0 purchases and 27 sales on the open market. Over the past 12 months that comes to a net sale of $44.1M. The latest trade was on 06/10.
Daniel Patrick O'Day
Chairman & CEO
- Company
- Gilead Sciences GILD
- First filing
- 23/01/26
- Trades
- 100 trades
- Buys / sales
- 0 / 27
- 12-month net buying
- −$44.1M
- Last trade
- 06/10
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 06/01 | 06/02 | 15,000 sh3 trades | $131.46avg. | $1,971,870.5 | −2.4% | |
| Open-market sale10b5-1 plan | 04/28 | 04/29 | 10,000 sh2 trades | $129.16avg. | $1,291,621 | −1.6% | |
Gilead SciencesGILD | Open-market sale10b5-1 plan | 03/27 | 03/30 | 10,000 sh | $136.82 | $1,368,200 | −1.5% |
| Open-market sale10b5-1 plan | 02/27 | 03/02 | 10,000 sh3 trades | $144.79avg. | $1,447,884.66 | −1.5% | |
Gilead SciencesGILD | Open-market sale10b5-1 plan | 02/05 | 02/06 | 115,640 sh | $150.00 | $17,346,000 | −15.9% |
| Open-market sale10b5-1 plan | 01/28 | 01/29 | 10,000 sh2 trades | $139.89avg. | $1,398,877.6 | −1.8% | |
Gilead SciencesGILD | Open-market sale10b5-1 plan | 01/23 | 01/26 | 115,640 sh | $135.00 | $15,611,400 | −16.9% |
Gilead SciencesGILD | Open-market sale10b5-1 plan | 25/12/29 | 25/12/30 | 10,000 sh | $124.83 | $1,248,300 | −1.7% |
| Open-market sale10b5-1 plan | 25/11/28 | 25/12/01 | 10,000 sh2 trades | $126.54avg. | $1,265,412.84 | −1.7% | |
| Open-market sale10b5-1 plan | 25/10/28 | 25/10/29 | 10,000 sh2 trades | $119.39avg. | $1,193,944.16 | −1.7% | |
| Open-market sale10b5-1 plan | 25/09/29 | 25/09/30 | 10,000 sh2 trades | $111.66avg. | $1,116,562.95 | −1.7% | |
Gilead SciencesGILD | Open-market sale10b5-1 plan | 25/08/28 | 25/08/29 | 10,000 sh | $113.63 | $1,136,300 | −1.7% |
| Open-market sale10b5-1 plan | 25/07/28 | 25/07/29 | 10,000 sh2 trades | $113.94avg. | $1,139,377.4 | −1.6% | |
| Open-market sale10b5-1 plan | 25/06/30 | 25/07/01 | 10,000 sh2 trades | $110.45avg. | $1,104,450 | −1.6% | |
| Open-market sale10b5-1 plan | 25/05/30 | 25/06/02 | 10,000 sh2 trades | $110.41avg. | $1,104,146.4 | −1.6% |